Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Nov 8, 2013, during market hours
10-Q filed Nov 8, 2013, 39 days after period end · 0001104659-13-082619
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $980.00K | $3.11M | $2.36M | $2.41M |
| EPS Diluted | -$0.29 | -$0.25 | -$0.27 | -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2013 · filed Nov 8, 2013 · 39 d after period end
+4.3% from the close of Nov 7, 2013 to the close of Nov 11, 2013, the first after the release.